Dehydroepiandrosterone therapy for ameleoration of prostate hypertrophy and sexual dysfunction
Patent 4835147 Issued on May 30, 1989. Estimated Expiration Date: 
May 6, 2007. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
May 6, 2007. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesTopical applications for preventing dry skin Method for treating diabetes using DHEA compounds DHEA Formulations and methods for treating dry skin Patent #: 4542129 InventorAssigneeApplicationNo. 07/046579 filed on 05/06/1987US Classes:514/178Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring systemExaminersPrimary: Robinson, Douglas W.Assistant: Lipovsky, Joseph A. Attorney, Agent or FirmInternational ClassA61K 31/565 (20060101)AbstractDehydroepiandrosterone and acceptable salts thereof are utilized for sexual disfunction therapy.Other References
| |
